Safety and Efficacy of TSHA-102 in Pediatric Females With Rett Syndrome (REVEAL Pediatric Study)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Laura Pisani, M.D.
Taysha Gene Therapies
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Chu Ste-Justine
Montreal, Quebec, Canada
- Children'S Neurosciences, Evelina London Children'S Hospital, Guy'S and St Thomas' Nhs Foundation Trust
London, United Kingdom
- Rush University Medical Center & Children'S Hospital
Chicago, Illinois, United States
- Gillette Children'S Specialty Healthcare
Saint Paul, Minnesota, United States
- Washington University, St. Louis
St Louis, Missouri, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Dec 2023
- Primary completion
- 2 Nov 2028
- Completion
- 2 Nov 2031
- Last update posted
- 15 Oct 2025
- Registered enrollment
- 6
- Registry id
- NCT06152237
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.